Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition

The use of a plus-maze to measure anxiety in the mouse

Lister, R. G. (1987) · Psychopharmacology · doi:10.1007/bf00177912 · Cited by 2,617 · see citing works

Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress

Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129 · see citing works

The molecular logic of endocannabinoid signalling

Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957 · see citing works

Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo–pituitary–adrenocortical responsiveness

Herman, J. P., Figueiredo, H., Mueller, N. K., Ulrich-Lai, Y., Ostrander, M. M., Choi, D. C., & Cullinan, W. E. (2003) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2003.07.001 · Cited by 1,586 · see citing works

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

Cravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., Martin, B. R., & Lichtman, A. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161191698 · Cited by 1,310 · see citing works

Modulation of anxiety through blockade of anandamide hydrolysis

Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293 · see citing works

An endocannabinoid mechanism for stress-induced analgesia

Hohmann, A. G., Suplita, R. L., Bolton, N. M., Neely, M. H., Fegley, D., Mangieri, R., Krey, J. F., Michael Walker, J., Holmes, P. V., Crystal, J. D., et al. (2005) · Nature · doi:10.1038/nature03658 · Cited by 778 · see citing works

Structure and function of fatty acid amide hydrolase

McKinney, M. K., & Cravatt, B. F. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133450 · Cited by 680 · see citing works

Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis

Gobbi, G., Bambico, F. R., Mangieri, R. A., Bortolato, M., Campolongo, P., Solinas, M., Cassano, T., Morgese, M. G., Debonnel, G., Duranti, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509591102 · Cited by 676 · see citing works

Cannabinoid physiology and pharmacology: 30 years of progress

Howlett, A. C., Breivogel, C. S., Childers, S. R., Deadwyler, S. A., Hampson, R. E., & Porrino, L. J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.030 · Cited by 608 · see citing works

Glucocorticoid Programming

SECKL, J. R., & MEANEY, M. J. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1314.006 · Cited by 556 · see citing works

Endocannabinoid Signaling Negatively Modulates Stress-Induced Activation of the Hypothalamic-Pituitary-Adrenal Axis

Patel, S., Roelke, C. T., Rademacher, D. J., Cullinan, W. E., & Hillard, C. J. (2004) · Endocrinology · doi:10.1210/en.2004-0638 · Cited by 475 · see citing works

CB1 Cannabinoid Receptor Inhibits Synaptic Release of Glutamate in Rat Dorsolateral Striatum

Gerdeman, G. L., & Lovinger, D. M. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.1.468 · Cited by 436 · see citing works

Characterization of the Fatty Acid Amide Hydrolase Inhibitor Cyclohexyl Carbamic Acid 3′-Carbamoyl-biphenyl-3-yl Ester (URB597): Effects on Anandamide and Oleoylethanolamide Deactivation

Fegley, D., Gaetani, S., Duranti, A., Tontini, A., Mor, M., Tarzia, G., & Piomelli, D. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078980 · Cited by 427 · see citing works

Pharmacological Evaluation of Cannabinoid Receptor Ligands in a Mouse Model of Anxiety: Further Evidence for an Anxiolytic Role for Endogenous Cannabinoid Signaling

Patel, S., & Hillard, C. J. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101287 · Cited by 390 · see citing works

Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome

Macfarlane, D. P., Forbes, S., & Walker, B. R. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0054 · Cited by 385 · see citing works

Downregulation of Endocannabinoid Signaling in the Hippocampus Following Chronic Unpredictable Stress

Hill, M. N., Patel, S., Carrier, E. J., Rademacher, D. J., Ormerod, B. K., Hillard, C. J., & Gorzalka, B. B. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300601 · Cited by 363 · see citing works

Antidepressant-like Activity of the Fatty Acid Amide Hydrolase Inhibitor URB597 in a Rat Model of Chronic Mild Stress

Bortolato, M., Mangieri, R. A., Fu, J., Kim, J. H., Arguello, O., Duranti, A., Tontini, A., Mor, M., Tarzia, G., & Piomelli, D. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.001 · Cited by 347 · see citing works

Dissociation of ACTH and glucocorticoids

Bornstein, S. R., Engeland, W. C., Ehrhart-Bornstein, M., & Herman, J. P. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.01.009 · Cited by 345 · see citing works

Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis

Beishuizen, A., & THIJS, L. G. (2003) · Journal of Endotoxin Research · doi:10.1179/096805103125001298 · Cited by 333 · see citing works

Neuroanatomical correlates of a lactate-induced anxiety attack.

Reiman, E., Raichle, M., Robins, E., Mintun, M., Fusselman, M. J., Fox, P. T., Price, J., & Hackman, K. A. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810060013003 · Cited by 319 · see citing works

Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic–pituitary–adrenal axis

Hill, M. N., McLaughlin, R. J., Morrish, A. C., Viau, V., Floresco, S. B., Hillard, C. J., & Gorzalka, B. B. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.114 · Cited by 304 · see citing works

Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum

Maccarrone, M., Rossi, S., Bari, M., Chiara, V. D., Fezza, F., Musella, A., Gasperi, V., Prosperetti, C., Bernardi, G., Finazzi‐Agrò, A., et al. (2008) · Nature Neuroscience · doi:10.1038/nn2042 · Cited by 293 · see citing works

Role in Anxiety Behavior of the Endocannabinoid System in the Prefrontal Cortex

Rubino, T., Realini, N., Castiglioni, C., Guidali, C., Viganò, D., Marras, E., Petrosino, S., Perletti, G., Maccarrone, M., Marzo, V. D., et al. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhm161 · Cited by 283 · see citing works

Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors

Moreira, F. A., Kaiser, N., Monory, K., & Lutz, B. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.07.005 · Cited by 282 · see citing works

Divergent Effects of Genetic Variation in Endocannabinoid Signaling on Human Threat- and Reward-Related Brain Function

Hariri, A. R., Gorka, A. X., Hyde, L. W., Kimak, M. A., Halder, I., Ducci, F., Ferrell, R. E., Goldman, D. A., & Manuck, S. B. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.047 · Cited by 250 · see citing works

Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons

Huang, C., Lo, S.-W., & Hsu, K. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0731e.x · Cited by 248 · see citing works

Distinct neural signatures for safety and danger in the amygdala and striatum of the mouse.

Rogan, M. T., Leon, K. S., Pérez, D. L., & Kandel, E. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.017 · Cited by 227 · see citing works

Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum

Szabó, B., Dorner, L., Pfreundtner, C., Nörenberg, W., & Starke, K. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00597-6 · Cited by 214 · see citing works

Anxiolytic Effects in Mice of a Dual Blocker of Fatty Acid Amide Hydrolase and Transient Receptor Potential Vanilloid Type-1 Channels

Micale, V., Cristino, L., Tamburella, A., Petrosino, S., Leggio, G. M., Drago, F., & Di Marzo, V. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.98 · Cited by 207 · see citing works

Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality

Naidu, P. S., Varvel, S. A., Ahn, K., Cravatt, B. F., Martin, B. R., & Lichtman, A. H. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0689-4 · Cited by 184 · see citing works

Anxiogenic-Like Behavioral Phenotype of Mice Deficient in Phosphodiesterase 4B (PDE4B)

Zhang, H., Huang, Y., Masood, A., Stolinski, L. R., Li, Y., Zhang, L., Dlaboga, D., Jin, S.-L. C., Conti, M., & O’Donnell, J. M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301537 · Cited by 180 · see citing works

Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance

Ganon-Elazar, E., & Akirav, I. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1223-09.2009 · Cited by 173 · see citing works

Abnormal Striatal GABA Transmission in the Mouse Model for the Fragile X Syndrome

Centonze, D., Rossi, S., Mercaldo, V., Napoli, I., Ciotti, M. T., De Chiara, V., Musella, A., Prosperetti, C., Calabresi, P., Bernardi, G., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.008 · Cited by 171 · see citing works

Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats

Haller, J., Barna, I., Barsvari, B., Gyimesi Pelczer, K., Yasar, S., Panlilio, L. V., & Goldberg, S. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1494-7 · Cited by 159 · see citing works

The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition

Scherma, M., Medalie, J., Fratta, W., Vadivel, S. K., Makriyannis, A., Piomelli, D., Mikics, É., Haller, J., Yaşar, S., Tanda, G., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.08.011 · Cited by 151 · see citing works

TRPV1 channels facilitate glutamate transmission in the striatum

Musella, A., Chiara, V. D., Rossi, S., Prosperetti, C., Bernardi, G., Maccarrone, M., & Centonze, D. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.09.001 · Cited by 146 · see citing works

Cannabinoid Tolerance and Dependence

Lichtman, A. H., & Martin, B. R. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_24 · Cited by 142 · see citing works

Estrogen recruits the endocannabinoid system to modulate emotionality.

Hill, M., Karacabeyli, E., & Gorzalka, B. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.02.003 · Cited by 141 · see citing works

Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat

Cippitelli, A., Cannella, N., Braconi, S., Duranti, A., Tontini, A., Bilbao, A., de Fonseca, F. R., Piomelli, D., & Ciccocioppo, R. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1104-0 · Cited by 112 · see citing works

Chronic Psychoemotional Stress Impairs Cannabinoid-Receptor-Mediated Control of GABA Transmission in the Striatum

Rossi, S., Chiara, V. D., Musella, A., Kusayanagi, H., Mataluni, G., Bernardi, G., Usiello, A., & Centonze, D. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.5346-07.2008 · Cited by 112 · see citing works

Cannabinoid Action Depends on Phosphorylation of Dopamine- and cAMP-Regulated Phosphoprotein of 32 kDa at the Protein Kinase A Site in Striatal Projection Neurons

Andersson, M., Usiello, A., Borgkvist, A., Pozzi, L., Dominguez, C. A., Fienberg, A. A., Svenningsson, P., Fredholm, B. B., Borrelli, E., Greengard, P., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1289-05.2005 · Cited by 110 · see citing works

A Model of Anxious Depression: Persistence of Behavioral Pathology

Avgustinovich, D. F., Kovalenko, I. L., & Kudryavtseva, N. N. (2005) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-005-0146-6 · Cited by 106 · see citing works

Putaminal gray matter volume decrease in panic disorder: an optimized voxel‐based morphometry study

Yoo, H. K., Kim, M. J., Kim, S. J., Sung, Y. H., Sim, M., Lee, Y. S., Song, S. Y., Kee, B. S., & Lyoo, I. K. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04394.x · Cited by 103 · see citing works

Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro

Hack, S. P., Vaughan, C. W., & Christie, M. J. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00205-3 · Cited by 85 · see citing works

Anandamide Regulates Postnatal Development of Long-Term Synaptic Plasticity in the Rat Dorsolateral Striatum

Ade, K. K., & Lovinger, D. M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2916-06.2007 · Cited by 83 · see citing works

Interactions between endocannabinoids and stress-induced decreased sensitivity to natural reward

Rademacher, D. J., & Hillard, C. J. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.12.013 · Cited by 79 · see citing works

Voluntary Exercise and Sucrose Consumption Enhance Cannabinoid CB1 Receptor Sensitivity in the Striatum

Chiara, V. D., Errico, F., Musella, A., Rossi, S., Mataluni, G., Sacchetti, L., Siracusano, A., Castelli, M., Cavasinni, F., Bernardi, G., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.141 · Cited by 78 · see citing works

Endocannabinoids Mediate the Effects of Acute Stress and Corticosterone on Sex Behavior

Coddington, E. J., Lewis, C. M., Rose, J. D., & Moore, F. L. (2006) · Endocrinology · doi:10.1210/en.2006-0740 · Cited by 78 · see citing works

The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons

Errico, F., Santini, E., Migliarini, S., Borgkvist, A., Centonze, D., Nasti, V., Carta, M., Chiara, V. D., Prosperetti, C., Spano, D., et al. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.10.007 · Cited by 76 · see citing works

Circadian Rhythms

Cutolo, M., Sulli, A., Pizzorni, C., Secchi, M. E., Soldano, S., SERIOLO, B., Straub, R. H., Otsa, K., & Maestroni, G. J. M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1351.027 · Cited by 72 · see citing works

Adenylyl cyclase‐5 activity in the nucleus accumbens regulates anxiety‐related behavior

Kim, K., Lee, K., Baek, I., Lim, C., Krishnan, V., Lee, J., Nestler, E. J., & Han, P. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05592.x · Cited by 66 · see citing works

Etiology and neurobiology of social anxiety disorder.

Mathew, S. J., & Ho, S. (2006) · PubMed · Cited by 55 · see citing works

Increased sensitivity to restraint stress and novelty-induced emotionality following long-term, high dose cannabinoid exposure

Hill, M. N., & Gorzalka, B. B. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.11.010 · Cited by 46 · see citing works

Presynaptic Cyclic Nucleotide-Gated Ion Channels Modulate Neurotransmission in the Mammalian Olfactory Bulb

Murphy, G. J., & Isaacson, J. S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00057-6 · Cited by 45 · see citing works

Chronic Gαs Signaling in the Striatum Increases Anxiety-Related Behaviors Independent of Developmental Effects

Favilla, C. G., Abel, T. G., & Kelly, M. P. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4986-08.2008 · Cited by 34 · see citing works

Mechanism of GABAB receptor‐mediated inhibition of spontaneous GABA release onto cerebellar Purkinje cells

Harvey, V. L., & Stephens, G. J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03505.x · Cited by 31 · see citing works

Mechanisms of stress in the brain

McEwen, B. S., Bowles, N. P., Gray, J. D., Hill, M. N., Hunter, R. G., Karatsoreos, I. N., & Nasca, C. (2015) · Nature Neuroscience · doi:10.1038/nn.4086 · Cited by 1,386 · see citing works

Neurobiological Interactions Between Stress and the Endocannabinoid System

Morena, M., Patel, S., Bains, J. S., & Hill, M. N. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.166 · Cited by 663 · see citing works

Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety

Gray, J. M., Vecchiarelli, H. A., Morena, M., Lee, T. T. Y., Hermanson, D. J., Kim, A. B., McLaughlin, R. J., Hassan, K. I., Kühne, C., Wotjak, C. T., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2737-14.2015 · Cited by 246 · see citing works

Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder

Hill, M. N., Campolongo, P., Yehuda, R., & Patel, S. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.162 · Cited by 239 · see citing works

The endocannabinoid system in anxiety, fear memory and habituation

Ruehle, S., Rey, A. A., Remmers, F., & Lutz, B. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111408958 · Cited by 236 · see citing works

The endocannabinoid system as a target for novel anxiolytic drugs

Patel, S., Hill, M. N., Cheer, J. F., Wotjak, C. T., & Holmes, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.033 · Cited by 233 · see citing works

Amygdala FAAH and anandamide: mediating protection and recovery from stress

Gunduz-Cinar, O., Hill, M. N., McEwen, B. S., & Holmes, A. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.08.008 · Cited by 229 · see citing works

Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure

Hill, M. N., Kumar, S. A., Filipski, S. B., Iverson, M., Stuhr, K. L., Keith, J. M., Cravatt, B. F., Hillard, C. J., Chattarji, S., & McEwen, B. S. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.90 · Cited by 222 · see citing works

The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling

Fogaça, M. V., Campos, A. C., Coelho, L. D., Duman, R. S., & Guimarães, F. S. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.03.001 · Cited by 208 · see citing works

Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats

Sciolino, N. R., Zhou, W., & Hohmann, A. G. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.04.010 · Cited by 179 · see citing works

Endocannabinoid system, stress and HPA axis

Micale, V., & Drago, F. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.07.039 · Cited by 189 · see citing works

Protective effects of elevated anandamide on stress and fear-related behaviors: translational evidence from humans and mice

Mayo, L. M., Asratian, A., Lindé, J., Holm, L., Nätt, D., Augier, G., Stensson, N., Vecchiarelli, H. A., Balsevich, G., Aukema, R. J., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0215-1 · Cited by 166 · see citing works

Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation

Shonesy, B. C., Bluett, R. J., Ramikie, T. S., Báldi, R., Hermanson, D. J., Kingsley, P. J., Marnett, L. J., Winder, D. G., Colbran, R. J., & Patel, S. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.11.001 · Cited by 155 · see citing works

Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation

Bluett, R. J., Gamble-George, J. C., Hermanson, D. J., Hartley, N. D., Marnett, L. J., & Patel, S. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.53 · Cited by 157 · see citing works

Therapeutic Potential of Inhibitors of Endocannabinoid Degradation for the Treatment of Stress-Related Hyperalgesia in an Animal Model of Chronic Pain

Lomazzo, E., Bîndilă, L., Remmers, F., Lerner, R., Schwitter, C., Hoheisel, U., & Lutz, B. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.198 · Cited by 141 · see citing works

Endocannabinoid System Components as Potential Biomarkers in Psychiatry

Navarrete, F., García‐Gutiérrez, M. S., Barba, R. J., Rubio, G., Gasparyan, A., Austrich-Olivares, A., & Manzanares, J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00315 · Cited by 134 · see citing works

Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation

Hermanson, D. J., Hartley, N. D., Gamble-George, J., Brown, N., Shonesy, B. C., Kingsley, P. J., Colbran, R. J., Reese, J., Marnett, L. J., & Patel, S. (2013) · Nature Neuroscience · doi:10.1038/nn.3480 · Cited by 126 · see citing works

Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids

Luchicchi, A., & Pistis, M. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8299-0 · Cited by 126 · see citing works

Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses

Hill, M. N., & Patel, S. (2013) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-3-19 · Cited by 117 · see citing works

Interleukin-1β Causes Anxiety by Interacting with the Endocannabinoid System

Rossi, S., Sacchetti, L., Napolitano, F., Chiara, V. D., Motta, C., Studer, V., Musella, A., Barbieri, F. R., Bari, M., Bernardi, G., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1515-12.2012 · Cited by 113 · see citing works

FAAH Gene Variation Moderates Stress Response and Symptom Severity in Patients with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence

Spagnolo, P. A., Ramchandani, V. A., Schwandt, M. L., Kwako, L. E., George, D. T., Mayo, L. M., Hillard, C. J., & Heilig, M. A. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13210 · Cited by 104 · see citing works

Dysfunction in Fatty Acid Amide Hydrolase Is Associated with Depressive-Like Behavior in Wistar Kyoto Rats

Vinod, K. Y., Xie, S., Psychoyos, D., Hungund, B. L., Cooper, T. B., & Tejani‐Butt, S. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036743 · Cited by 97 · see citing works

Endocannabinoids, cannabinoids and the regulation of anxiety

Petrie, G. N., Nastase, A. S., Aukema, R. J., & Hill, M. N. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108626 · Cited by 85 · see citing works

Constitutive increases in amygdalar corticotropin-releasing factor and fatty acid amide hydrolase drive an anxious phenotype

Natividad, L. A., Buczynski, M. W., Herman, M. A., Kirson, D., Oleata, C. S., Irimia, C., Polis, I., Ciccocioppo, R., Roberto, M., & Parsons, L. H. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.01.005 · Cited by 84 · see citing works

Cannabinoids and emotionality: a neuroanatomical perspective

McLaughlin, R. J., & Gobbi, G. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.052 · Cited by 82 · see citing works

2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics

Bedse, G., Hill, M. N., & Patel, S. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.01.015 · Cited by 75 · see citing works

Krill Products: An Overview of Animal Studies

Burri, L., & Johnsen, L. (2015) · Nutrients · doi:10.3390/nu7053300 · Cited by 71 · see citing works

Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety

Morena, M., Leitl, K. D., Vecchiarelli, H. A., Gray, J. M., Campolongo, P., & Hill, M. N. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.08.020 · Cited by 70 · see citing works

Temporal changes in N‐acylethanolamine content and metabolism throughout the peri‐adolescent period

Lee, T. T. ‐., Hill, M. N., Hillard, C. J., & Gorzalka, B. B. (2012) · Synapse · doi:10.1002/syn.21609 · Cited by 68 · see citing works

Age of stress exposure modulates the immediate and sustained effects of repeated stress on corticolimbic cannabinoid CB1 receptor binding in male rats

Lee, T. T. Y., & Hill, M. N. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.11.017 · Cited by 67 · see citing works

Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function

Gray, J. M., Wilson, C. D., Lee, T. T.-Y., Pittman, Q. J., Deussing, J. M., Hillard, C. J., McEwen, B. S., Schulkin, J. A., Karatsoreos, I. N., Patel, S., et al. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.01.004 · Cited by 66 · see citing works

Meet Your Stress Management Professionals: The Endocannabinoids

deRoon‐Cassini, T. A., Stollenwerk, T. M., Beatka, M. J., & Hillard, C. J. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.07.002 · Cited by 66 · see citing works

High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity

Fitzgibbon, M., Finn, D. P., & Roche, M. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv095 · Cited by 57 · see citing works

The potential of inhibitors of endocannabinoid metabolism as anxiolytic and antidepressive drugs—A practical view

Fowler, C. J. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.02.005 · Cited by 52 · see citing works

Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance

Maccarrone, M., Bernardi, G., Finazzi‐Agrò, A., & Centonze, D. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01277.x · Cited by 51 · see citing works

Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy

Voicu, V. A., Brehar, F.-M., Toader, C., Covache-Busuioc, R.-A., Corlatescu, A.-D., Bordeianu, A., Costin, H. P., Bratu, B.-G., Glavan, L.-A., & Ciurea, A. V. (2023) · Biomolecules · doi:10.3390/biom13091388 · Cited by 49 · see citing works

Endocannabinoid regulation of amyloid-induced neuroinflammation

Vázquez, C., Tolón, R. M., Grande, M. T., Caraza, M., Moreno, M., Koester, E. C., Villaescusa, B., Ruiz‐Valdepeñas, L., Fernández, J., Cravatt, B. F., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.08.003 · Cited by 48 · see citing works

Chronic stress leads to epigenetic dysregulation in the neuropeptide-Y and cannabinoid CB1 receptor genes in the mouse cingulate cortex

Lomazzo, E., König, F., Abassi, L., Jelinek, R., & Lutz, B. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.10.008 · Cited by 48 · see citing works

Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention

Zer‐Aviv, T. M., Segev, A., & Akirav, I. (2016) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000253 · Cited by 43 · see citing works

N-Arachidonoyl-serotonin in the basolateral amygdala increases anxiolytic behavior in the elevated plus maze

John, C. S., & Currie, P. J. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.05.025 · Cited by 41 · see citing works

The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission

Rossi, S., Motta, C., Musella, A., & Centonze, D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.09.022 · Cited by 41 · see citing works

Interleukin-1β alters the sensitivity of cannabinoid CB1 receptors controlling glutamate transmission in the striatum

Chiara, V. D., Motta, C., Rossi, S., Studer, V., Barbieri, F. R., Lauro, D., Bernardi, G., & Centonze, D. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.06.069 · Cited by 40 · see citing works

Sex- and hormone-dependent alterations in alcohol withdrawal-induced anxiety and corticolimbic endocannabinoid signaling

Henricks, A. M., Berger, A. L., Lugo, J. M., Baxter-Potter, L. N., Bieniasz, K. V., Petrie, G. N., Sticht, M. A., Hill, M. N., & McLaughlin, R. J. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.05.023 · Cited by 40 · see citing works

Cannabinoids prevent the differential long‐term effects of exposure to severe stress on hippocampal‐ and amygdala‐dependent memory and plasticity

Shoshan, N., Segev, A., Abush, H., Zer‐Aviv, T. M., & Akirav, I. (2017) · Hippocampus · doi:10.1002/hipo.22755 · Cited by 40 · see citing works

Circulating endocannabinoids and affect regulation in human subjects

Coccaro, E. F., Hill, M. N., Robinson, L., & Lee, R. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.03.009 · Cited by 34 · see citing works

Endocannabinoids, stress signaling, and the locus coeruleus-norepinephrine system

Wyrofsky, R. R., Reyes, B. A. S., Zhang, X.-Y., Bhatnagar, S., Kirby, L. G., & Bockstaele, E. J. V. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100176 · Cited by 31 · see citing works

Restoring glutamate homeostasis in the nucleus accumbens via endocannabinoid-mimetic drug prevents relapse to cocaine seeking behavior in rats

Zhang, L.-Y., Zhou, Y.-Q., Yu, Z., Zhang, X., Shi, J., & Shen, H. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-00955-1 · Cited by 29 · see citing works

Loss of striatal cannabinoid CB1 receptor function in attention‐deficit / hyperactivity disorder mice with point‐mutation of the dopamine transporter

Castelli, M., Federici, M., Rossi, S., Chiara, V. D., Napolitano, F., Studer, V., Motta, C., Sacchetti, L., Romano, R., Musella, A., et al. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07876.x · Cited by 28 · see citing works

Enhancing Endocannabinoid Control of Stress with Cannabidiol

Henson, J. D., Vitetta, L., Quezada, M., & Hall, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245852 · Cited by 29 · see citing works

Social defeat leads to changes in the endocannabinoid system: An overexpression of calreticulin and motor impairment in mice

Tomàs-Roig, J., Piscitelli, F., Gil, V., del Rı́o, J. A., Moore, T. P., Agbemenyah, H. Y., Salinas, G., Pommerenke, C., Lorenzen, S., Beißbarth, T., et al. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.01.036 · Cited by 24 · see citing works

Brain endocannabinoid signaling exhibits remarkable complexity

Gorzkiewicz, A., & Szemraj, J. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.06.012 · Cited by 24 · see citing works

The role of the endocannabinoid system as a therapeutic target for autism spectrum disorder: Lessons from behavioral studies on mouse models

Pietropaolo, S., & Marsicano, G. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.11.031 · Cited by 23 · see citing works

The role of the endocannabinoid system in autism spectrum disorders: Evidence from mouse studies

Pietropaolo, S., Bellocchio, L., Bouzón‐Arnáiz, I., & Yee, B. K. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.04.016 · Cited by 23 · see citing works

Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum

Mandolesi, G., Bullitta, S., Fresegna, D., Gentile, A., Vito, F. D., Dolcetti, E., Rizzo, F. R., Strimpakos, G., Centonze, D., & Musella, A. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.07.019 · Cited by 21 · see citing works

Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline?

Wilkerson, J. L., Bilbrey, J. A., Felix, J. S., Makriyannis, A., & McMahon, L. R. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173192 · Cited by 20 · see citing works

A life-course, epigenetic perspective on resilience in brain and body

McEwen, B. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813983-7.00001-x · Cited by 18 · see citing works

Cannabis use and posttraumatic stress disorder comorbidity: Epidemiology, biology and the potential for novel treatment approaches

Kondev, V., Winters, N. D., & Patel, S. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2020.09.007 · Cited by 17 · see citing works

Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis

Gilio, L., Fresegna, D., Gentile, A., Guadalupi, L., Sanna, K., Vito, F. D., Balletta, S., Caioli, S., Rizzo, F. R., Musella, A., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105817 · Cited by 17 · see citing works

Endocannabinoid Hydrolase Inhibitors: Potential Novel Anxiolytic Drugs

Zhao, H., Liu, Y., Cai, N., Liao, X., Tang, L., & Wang, Y. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s462785 · Cited by 14 · see citing works

Transcranial direct current stimulation (tDCS) produce anti-anxiety response in acute stress exposure rats via activation of amygdala CB1R

Fang, G., & Wang, Y. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113050 · Cited by 14 · see citing works

Differences in Spontaneously Avoiding or Approaching Mice Reflect Differences in CB1-Mediated Signaling of Dorsal Striatal Transmission

Laricchiuta, D., Rossi, S., Musella, A., Chiara, V. D., Cutuli, D., Centonze, D., & Petrosini, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033260 · Cited by 12 · see citing works

Behavioral and electrophysiological effects of endocannabinoid and dopaminergic systems on salient stimuli

Laricchiuta, D., Musella, A., Rossi, S., & Centonze, D. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00183 · Cited by 11 · see citing works

Cannabinoid CB1 Discrimination: Effects of Endocannabinoids and Catabolic Enzyme Inhibitors

Leonard, M. Z., Alapafuja, S. O., Ji, L., Shukla, V. G., Liu, Y., Nikas, S. P., Makriyannis, A., Bergman, J., & Kangas, B. D. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.244392 · Cited by 10 · see citing works

Circuit mechanisms governing endocannabinoid modulation of affective behaviour and stress adaptation

Loomba, N., & Patel, S. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00961-y · Cited by 10 · see citing works

Neurolipidomic insights into anxiety disorders: Uncovering lipid dynamics for potential therapeutic advances

Maehashi, S., Arora, K., Fisher, A. L., Schweitzer, D. R., & Akefe, I. O. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105741 · Cited by 9 · see citing works

Hippocampal CB1 receptor mediates antidepressant-like effect of synthetic cannabinoid-HU210 in acute despair reaction model in mice

Fang, G., & Wang, Y. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136953 · Cited by 6 · see citing works

Anxiogenic doses of rapamycin prevent URB597-induced anti-stress effects in socially defeated mice

Fusse, E. J., Scarante, F. F., Vicente, M. A., Marrubia, M. M., Turcato, F. C., Scomparin, D. S., Ribeiro, M. A., Figueiredo, M. J., Brigante, T. A. V., Guimarães, F. S., et al. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137519 · Cited by 5 · see citing works

Interactions Between Cannabinoid Signaling and Anxiety: A Comparative Analysis of Intervention Tools and Behavioral Effects

Aliczki, M., & Haller, J. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2294-9_4 · Cited by 5 · see citing works

Modulation of the Endogenous Cannabinoid System as a Therapeutic Target in the Treatment of Mental Health Disorders

Stratton, H. J. (2013) · Biochemistry & Pharmacology Open Access · doi:10.4172/2167-0501.s1-008 · Cited by 3 · see citing works

Interactions of Cannabis and Amphetamine-Type Stimulants

Tambaro, S., & Bortolato, M. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2294-9_16 · Cited by 4 · see citing works

Endocannabinoids, Stress, and Negative Affect

Berger, A. L., Henricks, A. M., Hill, M. N., & McLaughlin, R. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_3 · Cited by 2 · see citing works

Endocannabinoid Metabolism in Posttraumatic Stress Disorder: Results From a Neuroimaging Study With the Novel Fatty Acid Amide Hydrolase Probe, [C-11] Curb

Gaudette, E. V., Watling, S. E., Warsh, J. J., McCluskey, T., Tong, J., Houle, S., Rusjan, P., Rhind, S. G., Bazinet, R. P., Tyndale, R. F., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.02.729 · Cited by 2 · see citing works

Endocannabinoid System in a Planarian Model

Mustonen, K. L. (2010) · doi:10.12794/metadc33188 · Cited by 2 · see citing works

Endocannabinoid signaling and stress resilience

Hill, M. N., & Patel, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813983-7.00022-7 · Cited by 1 · see citing works

Cannabidiol prevents social avoidance, potentiation of cocaine reward and gene expression alterations induced by exposure to intermittent social defeat in mice

Martínez-Caballero, M. Á., Navarro, D., Calpe-López, C., Torregrosa, A. B., García-Pardo, M. P., Manzanares, J., & Aguilar, M. A. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110630 · Cited by 1 · see citing works

Cannabinoid Receptors Provide New Targets in Battling Anxiety

Stratton, H. J. (2012) · Biochemistry & Pharmacology Open Access · doi:10.4172/2167-0501.1000e139 · Cited by 1 · see citing works

Effect of Cannabinoids and Stress on Motor Maps and Behaviour

Scullion, K. (2015) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/25792

Anandamide and anxiety

Kroll, S. L., & Mayo, L. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19081-0.00002-0

Anandamide and mood disorders

Fitzgerald, J. M., & Hillard, C. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19081-0.00008-1

The Role of the Endocannabinoid System in Adolescent Suicidal Thoughts and Behaviors

Ely, S. L., & Marusak, H. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-87990-6_17

Endocannabinoids and the neurobiology of emotional states

Petrie, G. N., Lunge, A. R., Mayo, L. M., & Hill, M. N. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-13908-6.00021-9

Effects of glucocorticoid overload on central regulatory systems involved in responses to stress : preclinical investigations into putative molecular targets in neuroimaging of stress-related mood disorders

Ahmad, R. S. (2013)

Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition. Molecular pharmacology. 2010; 78:260–268. [PubMed: 20424126

Rossi, S., Chiara, V. D., Musella, R., Sacchetti, L., Cantarella, C., Castelli, M., Cavasinni, F., Motta, C., Studer, V., Bernardi, G., et al. (2016)

MOL #64196 1

Rossi, S., Chiara, V. D., Musella, R., Sacchetti, L., Cantarella, C., Cavasinni, F., Motta, C., Studer, V., Bernardi, G., Benjamin, F., et al. (2016)

Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors

Moreira, F. A., Kaiser, N., Monory, K., & Lutz, B. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.07.005 · Cited by 282 · see citing works

P.4.019 Disrupting astrocyte function in the prelimbic cortex induces a depressive-like phenotype and alters cerebral perfusion

McIntosh, A. L., Gormley, S., & Harkin, A. (2016) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(16)70109-x

Bed nucleus of the stria terminalis CB1 receptors and the FAAH enzyme modulate anxiety behavior depending on previous stress exposure

Borges‐Assis, A. B., Uliana, D. L., Hott, S. C., Guimarães, F. S., Lisboa, S. F. D. S., & Resstel, L. B. M. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110739 · Cited by 11 · see citing works